Tariq Imam

CIK: 0002055011

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (80.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LSTA

LISATA THERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2026
Award(A)
Direct
15K shares-
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2026
Tax Payment(F)
Direct
1.4K shares at avg. $1.97$3K
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2026
Tax Payment(F)
Direct
840 shares at avg. $1.97$2K
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2026
Tax Payment(F)
Direct
747 shares at avg. $1.97$1K
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2026
Tax Payment(F)
Direct
513 shares at avg. $1.97$1K

		Type	Shares	Price		Ownership
Jan 9, 2026	LSTA LISATA THERAPEUTICS, INC.	Award(A)	15,000	-	$0	Direct
Jan 9, 2026	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	1,401	$1.97	$2,760	Direct
Jan 9, 2026	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	840	$1.97	$1,655	Direct
Jan 9, 2026	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	747	$1.97	$1,472	Direct
Jan 9, 2026	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	513	$1.97	$1,011	Direct

1-5 of 5 transactions

About Imam Tariq

Imam Tariq (SEC CIK 0002055011) files insider reports with the SEC as SVP, Bus Dev, General Counsel of LISATA THERAPEUTICS, INC. (LSTA).

Signal8 holds 2 ownership filings by Imam Tariq (1 Form 3, 1 Form 4), filed between Feb 5, 2025 and Jan 13, 2026. Those filings report 5 transactions, the latest on Jan 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Imam Tariq's filings is in BASKING RIDGE, NJ.

Recent filings by Imam Tariq

Jan 9, 2026: Grant or award of LSTA shares (Form 4, code A).
Jan 9, 2026: Tax withholdings of LSTA shares (4 lines, Form 4, code F).

Other insiders filing for LISATA THERAPEUTICS, INC. (LSTA)

Farrow Jeffrey S, Director
LOVE TED W, Director
Lehrer-Graiwer Joshua, President & COO
Mazzo David J, President & CEO
Nisco James, SVP, Fin/Treas, Chief Actg Off
Buck Kristen K, EVP, R&D and CMO

How to read Form 4 transaction codes